Form 10-Q · Quarterly report
NXP Semiconductors 10-Q, filed Jul 28, 2026
- Filed
- CIK
- 0001413447
- Accession no.
- 0001413447-26-000045
Summary
NXP Semiconductors reported second-quarter 2026 revenue of $3.496 billion, up 19.5% year over year and 9.9% sequentially, with net income attributable to stockholders of $767 million and diluted earnings per share of $3.02. The company returned $360 million to shareholders through $256 million in dividends and $104 million in share repurchases.
Key points
- Revenue rose 19.5% year over year to $3,496 million, with year-over-year growth in the Automotive, Industrial & IoT, Communication Infrastructure & Other, and Mobile end markets.
- GAAP gross margin was 57.3% and GAAP operating margin was 30.6%; non-GAAP gross margin was 58.0% and non-GAAP operating margin was 35.1%.
- Cash flow from operations was $860 million, with $69 million in net capital expenditures, resulting in non-GAAP free cash flow of $791 million.
- NXP returned $360 million to shareholders in the quarter through $256 million in cash dividends and $104 million in common share repurchases.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management’s Discussion Overview Quarterly Financial Highlights •Revenue was $3,496 million, up 19.5% year-on-year; •GAAP gross margin was 57.3%, and GAAP operating margin was 30.6%; •Non-GAAP gross margin was 58.0%, and non-GAAP operating margin was 35.1%; •Cash flow from operations was $860 million, with net capital expenditures on property, plant and equipment of $69 million, resulting in non-GAAP free cash flow of $791 million; •During the second quarter of 2026, NXP returned capital to shareholders with the payment of $256 million in cash dividends and the repurchase of $104 million of its common shares, for a total capital return of $360 million. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.